Akkermansia muciniphila strain ATCC BAA-835 does not promote short-term intestinal inflammation in gnotobiotic interleukin-10-deficient mice.


Journal

Gut microbes
ISSN: 1949-0984
Titre abrégé: Gut Microbes
Pays: United States
ID NLM: 101495343

Informations de publication

Date de publication:
2019
Historique:
pubmed: 27 9 2018
medline: 8 8 2019
entrez: 26 9 2018
Statut: ppublish

Résumé

Akkermansia muciniphila is a common member of the intestinal microbiota of healthy human individuals. Its abundance is negatively associated with inflammatory bowel disease and metabolic disorders and the oral administration of A. muciniphila improves the symptoms of metabolic disease in mice. Therefore, A. muciniphila is a promising candidate for the treatment of type-2 diabetes and obesity. However, some studies using animal models of intestinal inflammation reported that A. muciniphila may exacerbate gut inflammation. Because of these contradictory reports the present study aimed to clarify the role of A. muciniphila in the development of intestinal inflammation and the conditions promoting it. For this purpose, the short-term colitogenic potential of A. muciniphila strain ATCC BAA-835 was investigated in colitis-prone, gnotobiotic IL-10-deficient (Il10

Identifiants

pubmed: 30252588
doi: 10.1080/19490976.2018.1511663
pmc: PMC6546315
doi:

Substances chimiques

IL10 protein, mouse 0
Inflammation Mediators 0
Interleukin-10 130068-27-8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

188-203

Références

Am J Clin Nutr. 1999 May;69(5):1035S-1045S
pubmed: 10232646
Infect Immun. 2000 Sep;68(9):5107-13
pubmed: 10948132
Nucleic Acids Res. 2001 May 1;29(9):e45
pubmed: 11328886
Appl Environ Microbiol. 2002 Jan;68(1):219-26
pubmed: 11772630
Am J Pathol. 2002 Jun;160(6):2253-7
pubmed: 12057927
Inflamm Bowel Dis. 2003 Mar;9(2):87-97
pubmed: 12769442
Gastroenterology. 2004 Aug;127(2):412-21
pubmed: 15300573
Int J Syst Evol Microbiol. 2004 Sep;54(Pt 5):1469-76
pubmed: 15388697
J Microbiol Methods. 2005 Jun;61(3):369-79
pubmed: 15767013
Gastroenterology. 2005 Apr;128(4):891-906
pubmed: 15825073
Dig Dis Sci. 2005 May;50(5):905-13
pubmed: 15906767
Gut. 2007 May;56(5):669-75
pubmed: 17028128
PLoS Biol. 2006 Nov;4(12):e413
pubmed: 17132046
Gut. 2007 Jul;56(7):941-8
pubmed: 17255219
J Nutr. 2007 Mar;137(3 Suppl 2):751S-5S
pubmed: 17311972
Inflamm Bowel Dis. 2007 Dec;13(12):1457-66
pubmed: 17763473
Appl Environ Microbiol. 2007 Dec;73(23):7767-70
pubmed: 17933936
ISME J. 2007 Sep;1(5):403-18
pubmed: 18043660
Appl Environ Microbiol. 2008 Mar;74(5):1646-8
pubmed: 18083887
Environ Microbiol. 2009 Jun;11(6):1562-71
pubmed: 19245530
Gut. 2011 Jan;60(1):34-40
pubmed: 19926616
Am J Gastroenterol. 2010 Nov;105(11):2420-8
pubmed: 20648002
Gut Microbes. 2011 Jan-Feb;2(1):25-33
pubmed: 21637015
Gastroenterology. 2011 Nov;141(5):1842-51.e1-10
pubmed: 21726510
Front Microbiol. 2011 Aug 01;2:166
pubmed: 21904534
Appl Environ Microbiol. 1990 Jun;56(6):1919-25
pubmed: 2200342
Inflamm Bowel Dis. 2012 May;18(5):943-54
pubmed: 22238116
Obesity (Silver Spring). 2012 Nov;20(11):2257-61
pubmed: 22546742
PLoS One. 2012;7(9):e44328
pubmed: 22957064
Gut. 2014 Feb;63(2):281-91
pubmed: 23426893
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4720-5
pubmed: 23487774
Proc Natl Acad Sci U S A. 2013 May 28;110(22):9066-71
pubmed: 23671105
Gut. 2014 May;63(5):727-35
pubmed: 23804561
Gut Microbes. 2013 Jul-Aug;4(4):316-24
pubmed: 23822920
Environ Microbiol. 2014 Sep;16(9):2966-79
pubmed: 23855897
PLoS One. 2013 Aug 06;8(8):e70803
pubmed: 23940645
PLoS One. 2013 Sep 10;8(9):e74963
pubmed: 24040367
PLoS One. 2013 Oct 24;8(10):e76520
pubmed: 24204633
Int J Mol Med. 2014 Feb;33(2):333-40
pubmed: 24285285
J Bacteriol. 1988 Feb;170(2):720-6
pubmed: 2448289
World J Gastroenterol. 2014 Feb 28;20(8):2051-61
pubmed: 24587679
Infect Immun. 2014 Jun;82(6):2239-46
pubmed: 24643531
MBio. 2014 Sep 30;5(5):e01530-14
pubmed: 25271283
Diabetes. 2015 Aug;64(8):2847-58
pubmed: 25845659
Gut. 2016 Mar;65(3):426-36
pubmed: 26100928
Inflamm Bowel Dis. 2015 Aug;21(8):1967-75
pubmed: 26164667
Cell Host Microbe. 2015 Nov 11;18(5):582-92
pubmed: 26526499
Sci Rep. 2015 Nov 13;5:16643
pubmed: 26563823
Microb Pathog. 2017 May;106:171-181
pubmed: 26875998
J Mol Endocrinol. 2017 Jan;58(1):1-14
pubmed: 27821438
Nat Med. 2017 Jan;23(1):107-113
pubmed: 27892954
Sci Rep. 2016 Dec 16;6:39399
pubmed: 27982124
Benef Microbes. 2017 Apr 26;8(2):163-169
pubmed: 28116930
Cell Rep. 2017 Apr 25;19(4):733-745
pubmed: 28445725
Nutrients. 2017 Jun 29;9(7):null
pubmed: 28661454
Front Microbiol. 2017 Sep 22;8:1765
pubmed: 29018410
BMC Genomics. 2017 Oct 18;18(1):800
pubmed: 29047329
Cell. 1993 Oct 22;75(2):263-74
pubmed: 8402911
J Clin Invest. 1996 Aug 15;98(4):1010-20
pubmed: 8770874
Infect Immun. 1998 Nov;66(11):5224-31
pubmed: 9784526

Auteurs

Christiane Ring (C)

a Department Gastrointestinal Microbiology , German Institute of Human Nutrition Potsdam-Rehbruecke , Nuthetal , Germany.

Robert Klopfleisch (R)

b Institute of Veterinary Pathology , Freie Universitaet Berlin , Berlin , Germany.

Katja Dahlke (K)

a Department Gastrointestinal Microbiology , German Institute of Human Nutrition Potsdam-Rehbruecke , Nuthetal , Germany.

Marijana Basic (M)

c Institute for Laboratory Animal Science and Central Animal Facility , Hannover Medical School , Hannover , Germany.

André Bleich (A)

c Institute for Laboratory Animal Science and Central Animal Facility , Hannover Medical School , Hannover , Germany.

Michael Blaut (M)

a Department Gastrointestinal Microbiology , German Institute of Human Nutrition Potsdam-Rehbruecke , Nuthetal , Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH